Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé Cboe Europe 10:11:09 08/10/2026			Varia. 5j.	Varia. 1 janv.
1 770,50 ^GBX	-1,12%		-3,66%	-3,26%

08:56	GSK plc : JP Morgan maintient son opinion vendeuse	ZD
07/10	GSK plc : Berenberg reste à l'achat	ZD

Autres langues

07/10	Die Rally wird langsam einsam
07/10	Afternoon Meeting: Un rally cada vez más solitario
07/10	The Rally Is Getting Lonely
07/10	Morning Meeting: La carrera desbocada de la IA deja rezagados
07/10	Morning Meeting: Das rasante KI-Tempo dünnt das Feld aus
07/10	AI's Breakneck Pace Thins the Ranks
06/10	European Stocks Close Higher in Tuesday Trading Amid Political Unrest in France, Spain
06/10	GSK-backed ViiV Healthcare's Cabenuva Meets Primary Endpoint in Late-stage HIV Trial
06/10	GSK celebrates "important insights" from Cabenuva study
06/10	GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint
06/10	ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia
05/10	European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
02/10	Major drugmakers turn to China for licensing deals
30/09	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
30/09	Major drugmakers turn to China for licensing deals
30/09	Wave Life Sciences Earns $12 Million Milestone as GSK Advances Liver Drug
30/09	Wave Life Sciences, Inc. Announces GSK?s Selection Of siRNA Program To Transition To GSK For Further Development
30/09	Lonza nominiert Pearl Huang für Verwaltungsrat - Mäder geht
29/09	Pharma sector doubles down on AI to slash costs, timelines
29/09	Stocks rise as oil prices edge down
29/09	FTSE 100 hits two-week low as energy stocks slide
29/09	WINNERS & LOSERS: Vesuvius soars on bid; Zigup lifts outlook
29/09	Stocks rise as pharma and miners advance
28/09	AN2 Therapeutics, Inc. Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
28/09	AN2 Therapeutics Gets Gates Foundation Funding Extension for Tuberculosis Research